13790 Medical Management in Endometriosis: Does Class of Medication Predict Compliance at 12-, 24- and 36-Months after Beginning Treatment?

Clarence A. Broomfield, J. Lee, Cecilia Ng, Rebecca Deans, Erin Nesbitt‐Hawes, JA Abbott
In: Journal of Minimally Invasive Gynecology · 2025 · vol. 32(11) , pp. S86–S87 · doi:10.1016/j.jmig.2025.09.260 · W4415407096
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated whether the class of medication used for endometriosis management influences patient compliance at 12, 24, and 36 months of treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK